Yahoo Finance24d
PepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1
BOSTON, February 24, 2025--(BUSINESS WIRE)--PepGen Inc. (Nasdaq ... "These results far exceeded our expectations for splicing correction following a single dose of PGN-EDODM1.
Nasdaq24d
PepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1
BOSTON--(BUSINESS WIRE)-- PepGen Inc. (Nasdaq ... “These results far exceeded our expectations for splicing correction following a single dose of PGN-EDODM1. Mis-splicing is the underlying ...